Promakhos Therapeutics

A biotechnology company developing medicines for inflammatory diseases. It uses insights from patient samples to target underlying causes of inflammation, aiming to restore immune-system balance and the body's ability to resolve inflammation and heal tissue rather than broadly suppressing immunity. Its preclinical pipeline includes a candidate for Crohn's disease.